Significant reduction of TDP-43 observed in ALS clinical trial results NeuroSense's study…
NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study
Browsing Category
Featured
1660 posts
DISC Surgery Center at Palm Beach Opens with Elite Team of Specialists
New center brings advanced spine and orthopedic care to Palm Beach area.…
Breakthrough Cancer Initiative Launched for Pancreatic Cancer Research
New collaborative effort aims to advance RAS-directed therapies for pancreatic cancer. Collaboration…
MiniMed Appoints Alcon CEO David Endicott and Linnea Burman to Its Board of Directors
Leadership expansion with two new members for MiniMed's board. Expansion of MiniMed's…
WellSense Health Plan Partners with Bwell to Transform the Member Experience
New partnership aims to enhance healthcare engagement for members. WellSense Health Plan…
Nuvation Bio Submits Application for Taletrectinib in Advanced ROS1-Positive NSCLC
Application seeks approval for advanced non-small cell lung cancer treatment. Nuvation Bio…
AleBund Pharmaceuticals Debuts on the HKEX Main Board
AleBund Pharmaceuticals begins trading on the Hong Kong Stock Exchange. AleBund Pharmaceuticals…
Theravance Biopharma to Be Acquired by Zymeworks for $17.00 Per Share
Theravance Biopharma has reached an acquisition agreement with Zymeworks. Acquisition agreement reached…
Health in Tech Added to Membership of Russell Microcap Index
Health in Tech joins Russell Microcap Index, marking a significant milestone. Health…
Sisram Medical’s China Manufacturing Facility Begins Operations
New facility marks local production of Alma Rejuve in China. Sisram Medical…